Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tangshen'an is a Traditional Chinese Medicine (TCM) formulation used primarily for the management of diabetic nephropathy and related kidney complications. It is composed of multiple herbal ingredients, commonly including astragalus root (Astragalus membranaceus), rhubarb root (Rheum palmatum), and other botanicals traditionally believed to support kidney function, reduce proteinuria, and improve microcirculation. The mechanism of action is thought to involve anti-inflammatory effects, antioxidative stress reduction, improvement in renal hemodynamics, and modulation of immune responses. Tangshen'an has been studied in clinical settings in China for its potential benefits in slowing the progression of diabetic nephropathy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tangshen'an.